Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) — Cash Flow-to-Debt Ratio
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (301408) has a Cash Flow-to-Debt Ratio of 0.25x as of December 2025, meaning its operating cash flow of CN¥837.18 Million could theoretically repay 0% of its total liabilities (CN¥3.33 Billion) in one year. Check total reinvestment intensity of Anhui Huaren Health Pharmaceutical Co. L to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A across 5 annual periods. Also explore Anhui Huaren Health Pharmaceutical Co. L assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A (2021–2025)
Year-by-year debt coverage analysis for Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A. For market capitalisation and broader financial context, see Anhui Huaren Health Pharmaceutical Co. L market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.25x | CN¥837.18 Million | CN¥3.33 Billion | ▲ +21.9% |
| 2024 | 0.21x | CN¥571.76 Million | CN¥2.77 Billion | ▲ +314.4% |
| 2023 | 0.05x | CN¥131.37 Million | CN¥2.64 Billion | ▼ -53.3% |
| 2022 | 0.11x | CN¥173.84 Million | CN¥1.63 Billion | ▼ -10.1% |
| 2021 | 0.12x | CN¥140.82 Million | CN¥1.19 Billion | — |